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Abstract
Background: Visual estimation of blood loss following delivery often under-reports actual bleed volume. To
improve accuracy, quantitative blood loss measurement was introduced for all births in the 12 hospitals providing
maternity care in Wales. This intervention was incorporated into a quality improvement programme (Obstetric
Bleeding Strategy for Wales, OBS Cymru). We report the incidence of postpartum haemorrhage in Wales over a 1-
year period using quantitative measurement.
Methods: This prospective, consecutive cohort included all 31,341 women giving birth in Wales in 2017.
Standardised training was cascaded to maternity staff in all 12 hospitals in Wales. The training comprised mock-
scenarios, a video and team drills. Uptake of quantitative blood loss measurement was audited at each centre. Data
on postpartum haemorrhage of > 1000 mL were collected and analysed according to mode of delivery. Data on
blood loss for all maternities was from the NHS Wales Informatics Service.
Results: Biannual audit data demonstrated an increase in quantitative measurement from 52.1 to 87.8% (P < 0.001).
The incidence (95% confidence intervals, CI) of postpartum haemorrhage of > 1000 mL, > 1500 mL and > 2000 mL
was 8.6% (8.3 to 8.9), 3.3% (3.1 to 3.5) and 1.3% (1.2 to 1.4), respectively compared to 5%, 2% and 0.8% in the year
before OBS Cymru. The incidence (95% CI) of bleeds of > 1000 mL was similar across the 12 hospitals despite
widely varied size, staffing levels and case mix, median (25th to 75th centile) 8.6% (7.8–9.6). The incidence of PPH
varied with mode of delivery and was mean (95% CI) 4.9% (4.6–5.2) for unassisted vaginal deliveries, 18.4 (17.1–19.8)
for instrumental vaginal deliveries, 8.5 (7.7–9.4) for elective caesarean section and 19.8 (18.6–21.0) for non-elective
caesarean sections.
Conclusions: Quantitative measurement of blood loss is feasible in all hospitals providing maternity care and is
associated with detection of higher rates of postpartum haemorrhage. These results have implications for the
definition of abnormal blood loss after childbirth and for management and research of postpartum haemorrhage.
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Background
In the UK, postpartum haemorrhage (PPH) is defined by
The Royal College of Obstetrics and Gynaecology
(RCOG) as minor for bleeds between 500 and 1000mL,
moderate > 1000–2000mL and severe > 2000mL [1, 2].
Other groups define PPH > 1000 mL as severe [3–6] and
a core outcome set, based on an expert consensus and
Delphi analysis, recommended the use of ≥1000mL as a
key outcome measure for treatment and prevention of
PPH [7]. Current PPH management guidelines advocate
escalation of care to more senior staff based on specific
volumes of blood loss, rate of bleeding and patient’s vital
signs [1, 8, 9]. In order to apply these guidelines in rou-
tine clinical practice, clinicians need to be able to meas-
ure blood loss accurately and easily.
Defining the incidence of PPH, and comparing results
of studies, is hampered by the lack of a standardised ap-
proach to blood loss assessment [2]. Visual estimation,
although widely used, is inaccurate and often associated
with under-reporting of actual blood loss, especially in
cases of large volumes of PPH [3–5, 10–19]. Systematic
reviews confirm that the incidence of PPH is higher with
quantitative measurement, as opposed to visual estima-
tion and this leads to inaccurate reporting of the inci-
dence and severity of PPH [3–5].
Quantitative blood loss (QBL) measurement, using
gravimetric and volumetric techniques, is more accur-
ate than visual estimation, both in simulations and
clinical practice [10, 13, 15, 19, 20] and so gives a
more representative and reproducible measure of the
incidence and severity of PPH, although all methods
have shortcomings. It remains unclear, however,
whether quantitative measurement is feasible in all
clinical settings, after all types of deliveries and out-
side of routine hours. Furthermore quantitative meas-
urement is not routinely practiced in all hospitals and
for all maternities [21].
We report on the incidence of PPH after the intro-
duction of standardised, QBL measurement after all
modes of delivery and in all maternity settings in
Wales as part of a national quality improvement
programme called The Obstetric Bleeding Strategy
Wales (OBS Cymru) [22].
Methods
The lead research and development office (Cardiff and
Vale University Health Board) categorised the project as
a quality improvement initiative, which did not require
ethical approval or individual patient consent to collect
and report data. The project was registered within each
health care region of Wales as a quality improvement
programme and data sharing agreements enabled infor-
mation to be collected in a national database. Patient
and public representatives were members of the OBS
Cymru steering committee and were involved in the de-
sign and conduct of the quality improvement
programme.
Between January and March 2017 the quality improve-
ment programme introduced a package of interventions
into all 12 hospitals providing maternity care in Wales.
These hospitals provide care in both midwifery- and
obstetrician-led settings. A key intervention was the
introduction of cumulative, QBL measurement for all
births, irrespective of the perceived risk of bleeding.
QBL measurement was started at delivery although, in
cases of antepartum haemorrhage, bleeding within 24 h
before birth was included in the cumulative calculation.
QBL measurement was defined as the combined blood
loss from all gravimetric and volumetric sources and was
continued until the treating clinicians were confident
that abnormal bleeding had stopped. The gravimetric
technique included weighing all blood soaked swabs and
under-buttocks incontinence bed pads and subtracting
their known dry weight and has been previously de-
scribed [8, 15, 20]. At unassisted vaginal delivery, under-
buttocks incontinence pads were changed immediately
after delivery to discard amniotic fluid, and subsequent
fluid on new pads was assumed to be blood and there-
fore measured. Blood on bed linen was weighed and the
dry weight subtracted. For instrumental vaginal deliver-
ies, conical under buttock drapes were placed after
amniotomy. Conical under buttock drapes were not used
for unassisted vaginal deliveries. In the operating theatre
the volume of blood loss collected in suction containers
was calculated following consensus agreement regarding
the subtraction of amniotic fluid. A national training
package was developed to support implementation based
on knowledge gained from previous PPH studies at one
hospital where accurate measurement was required to
define research study entry [23–26]. This included an
on-line training package, https://www.youtube.com/
watch?v=3aKse0HbAac (accessed 14th Mar 2020) devel-
oped in collaboration with the Association of Women's
Health, Obstetric and Neonatal Nurses (AWHONN).
At each of the 12 hospitals providing maternity care
the local leadership team, consisting of a senior midwife,
obstetrician and anaesthetist, designated a midwife with
an interest in quality improvement and PPH to be their
local champion midwife. The national OBS Cymru se-
nior midwives and medical clinical leadership fellows de-
livered standardised training to the local midwifery
champions. This consisted of scenario based teaching
using mock blood loss simulation, teaching video and
training drills. The local champion midwives cascaded
training to midwives, maternity support workers and
theatre teams. OBS Cymru senior midwives delivered
training to undergraduate midwives within their univer-
sity courses throughout Wales.
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The accuracy of the method for blood loss measure-
ment was assessed in Cardiff. In 372 maternities, where
the mean (range) blood loss was 643 (10–3000) mL, the
correlation coefficient between quantitatively measured
blood loss and fall in haemoglobin adjusted for red
blood cell transfusion was r = − 0.57. The correlation
was similar in the operating theatre r = − 0.58 and the
birthing room (including both midwifery and
obstetrician-led care) r = − 0.55 (manuscript accepted).
Audit cycles to assess uptake of QBL measurement
were performed by the 12 hospitals providing maternity
care in Wales. Champion midwives reported the method
of blood loss measurement for all maternities during a
week or for at least 30 consecutive births. The mode and
place of delivery, volume of blood loss and method of
measurement for each item were recorded. When all
items used to collect blood during the delivery were ap-
propriately measured, blood loss was considered to have
been quantitatively measured. A baseline audit was per-
formed in October 2016, before OBS Cymru had started,
with repeat cycles in June 2017 and December 2017.
Information on blood loss for all maternities in Wales
in the year before the introduction of quantitative blood
loss measurement and the establishment of the OBS
Cymru database was accessed through The NHS Wales
Informatics Service (1st April 2015 to 31st March 2016).
This anonymous dataset did not link blood loss with
mode of birth or hospital site and was automatically
complied from local maternity datasets. A national OBS
Cymru database was established by 1000 Lives Improve-
ment, the national quality improvement service for NHS
Wales, to capture information about maternities where
blood loss was 1000 mL or more. Data in the OBS
Cymru database included mode of delivery, aetiology of
bleeding, whether blood loss was measured quantita-
tively or estimated visually and total volume of blood
loss. The OBS Cymru database did not collect informa-
tion for PPH < 1000mL. Information on the mode of de-
livery for all maternities in 2017 was obtained from the
Welsh Maternity Indicators data set [27]. In four mater-
nity units data were collected that linked the volume of
blood loss to mode of delivery after all births (as op-
posed to only for bleeds > 1000mL) after quantitative
measurement had been adopted, these data included
both midwifery- and obstetric-led births. The 4 units
were the smallest, largest and two medium size mater-
nity units so that a wide spread of practice and case mix
could be observed.
Continuous data are analysed descriptively and pre-
sented as median, interquartile range and range, mean
and 95% confidence intervals (CI). Categorical values are
presented as number and percent. The incidence of PPH
> 1000, > 1500 and > 2000mL were calculated using bi-
nomial confidence intervals using the Hmisc R library
4.1.1 implementation of the Wilson method. R 3.2 was
used for all analyses. Differences in the uptake of blood
loss measurement were investigated using Chi square
test.
Results
Between 1st January and 31st December 2017 there were
31,341 maternities in Wales. The median (range) num-
ber of maternities (including both midwifery- and
obstetrician-led care) in the 12 hospitals was 2279 (538
to 5668). Throughout Wales in 2017, the vaginal delivery
rate was 73.9% (9.9% assisted and 64.0% unassisted),
12.7% were elective caesarean sections, and 13.4% were
non-elective caesarean sections [27].
The proportion of all maternities, by mode of delivery,
that had QBL measurement performed prior to the OBS
Cymru initiative and at two subsequent time points was
assessed by audit and the results are shown in Fig. 1.
QBL measurement increased from 52.1% in October
2016 (before the quality improvement initiative) to
87.8% in December 2017 (P < 0.001). An increase in the
proportion of women having all blood loss measured
was observed for all modes of delivery but was especially
marked for vaginal deliveries where the proportion in-
creased from 37.0 to 84.2%. The increase was statistically
significant for assisted and unassisted vaginal deliveries
and elective caesarean sections but not for non-elective
caesarean sections, which had a high rate before the pro-
ject (Fig. 1). The proportion of women who were in-
cluded on the OBS Cymru database (with episodes of
PPH > 1000 ml) who had blood loss measured quantita-
tively rather than by visually estimated increased from
525/677 (77.5%) in the first 3 months of 2017 to 714/
718 (99.4%) in the last 3 months of 2017.
In 2017 the incidence (95% CI) of cases with blood
loss > 1000 mL in Wales was 8.6 (8.3 to 8.9) per 100 ma-
ternities whilst that of severe PPH (> 2000mL) was 1.3
(1.2 to 1.4). The number of episodes of moderate and se-
vere PPH, the incidence per 100 maternities and vari-
ation in hospitals providing maternity care across Wales
is shown in Table 1 and Fig. 2. For comparison, the inci-
dence of PPH between 1st April 2015 and 31st March
2016, before the introduction of quantitative measure-
ment, was 5.1, 2.0 and 0.82 per 100 maternities for
bleeds > 1000, > 1500 and > 2000 mL, respectively.
Therefore the introduction of quantitative blood loss
measurement in Wales was associated with was in-
creased detection of PPH > 1000, > 1500 and > 2000mL
by 169, 165 and 159%, respectively.
The incidence of PPH, dependent on mode of delivery,
is shown in Table 2. PPH of all severities was most com-
mon for non-elective caesarean sections followed by in-
strumental vaginal deliveries and least common for
unassisted vaginal deliveries.
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The OBS Cymru database recorded information
about blood loss > 1000 mL and so could not be used
to investigate the incidence of PPH between 500 and
1000 mL. Data about blood loss at the time of all
births, included both midwifery- and obstetrician-led
care, linked to mode of delivery, were available from
four maternity units. The incidence of PPH ≥500 mL
for all maternities in Wales in 2017 was 34.0%, ac-
cording to the NHS Wales Informatics Service. The
incidence (95% CI) of PPH ≥500 mL in the four ma-
ternity units where more detailed information was
available was 33 (32–34) per 100 maternities demon-
strating that these centres were representative of the
country as a whole. The median total blood loss for
all births was similar in each of the four maternity
units for all modes of delivery, irrespective of the size
of the unit and case mix. The median (IQR) blood
loss for all deliveries at the four centres combined
was 350 (219–600) mL. Unassisted vaginal deliveries
had the lowest blood loss, median 300 mL, but instru-
mental vaginal deliveries (median 500 mL) were simi-
lar to caesarean sections. The incidence of bleeds
≥500 mL in the 4 units varied between 30.9 and
40.7% (Table 3). There was remarkable consistency
between maternity units for unassisted vaginal deliver-
ies with an overall incidence of 18.2% (range 17.4 to
Fig. 1 Objective measurement of all blood loss by mode of delivery. The proportion of maternities where all blood loss was objectively measured
is shown for October 2016, before OBS Cymru started and subsequently in June and December 2017. The proportion of maternities where blood
loss was measured was compared between October 2016 and December 2017 by the Chi Square test. Category 1 caesarean sections are where
there is immediate threat to life of mother or fetus, category 2 maternal or fetal compromise that is not immediately life-threatening, category 3
is no maternal or fetal compromise but needs early delivery and category 4 is timed to suit woman and staff
Table 1 The incidence of moderate and severe postpartum haemorrhage in Wales in 2017
Volume of postpartum
haemorrhage
Number of episodes of postpartum
haemorrhage in Walesa
Incidence (95% CI) per 100
maternities in Walesa
Incidence of PPH per 100 maternities in the 12
maternity unitsa in Wales
Median
(IQR)
> 1000mL 2688 8.6 (8.3–8.9) 8.6 (7.8–9.6)
> 1500mL 1039 3.3 (3.1–3.5) 3.6 (2.7–4.0)
> 2000mL 404 1.3 (1.2–1.4) 1.5 (1.0–1.7)
The incidence of bleeds > 2000 mL and > 1500 are subgroups of > 1000 mL. There were 1649 bleed between > 1000 and 1500 mL and 635 between > 1500 and
2000 mL. aData include midwifery and obstetrician-led care from all 12 maternity units in Wales. The incidence (95% CI) is for all maternities in Wales with the
denominator n = 31,341. The incidence at each of the 12 obstetric units is described by median and interquartile range (IQR) to describe the variation
between hospitals
Bell et al. BMC Pregnancy and Childbirth          (2020) 20:271 Page 4 of 9
19.1%). Wider variation in the incidence of PPH
≥500 mL was observed between centres for non-
elective caesarean sections.
Discussion
In this manuscript we report on the national incidence
of PPH after standardised, QBL measurement was
adopted by all 12 hospitals providing maternity care in
Wales. The method identified an incidence of PPH >
1000 mL of 8.6% and > 2000mL of 1.3% which was an
increase of about 160% compared to before the initiative.
In a subgroup of four maternity units of widely varying
size, the incidence of PPH ≥500mL was between 30.9
and 40.7%. The incidence of PPH reported here, after
the introduction of QBL measurement, is higher than in
many previous reports and has potential implications for
clinical practice and research.
The initiative led to an increase in QBL measurement
for all modes of delivery. Improvement was observed in
the theatre environment even though high compliance
with quantitative measurement had been present before
the programme. This demonstrates that quantitative
measurement of blood loss is feasible in all hospital-
based maternity settings, including midwifery- and
obstetrician-led care, and outside of routine hours. The
increased proportion of women with measured blood
loss has been sustained over at least 1 year and been em-
bedded in undergraduate midwifery education in Wales.
A systematic review between 1997 and 2002 reported
an incidence of PPH ≥500 mL of 7.2% for subjectively
and 10.4% for quantitative assessed blood loss [4]. A
study from France reported PPH ≥500 mL at 10% [5] for
quantitative measured blood loss and an international
systematic review reported 14.2% [3]. These figures are
at least 50% lower than the incidence of 30.9–40.7% ob-
served in Wales in 2017 where quantitative measure-
ment was started at delivery and the same method,
confirmed by audit, was used throughout the country. In
the context of clinical studies performed more recently,
a UK group reported the incidence of PPH ≥500 mL to
be 33.7% [11] and in Australia 22% [6] which are in line
with our findings established in routine care.
Systematic reviews report an incidence of PPH > 1000
mL for quantitatively measured blood loss to be between
2% [5] and 4.2% [3]. A Swedish study reported bleeds >
1000 mL to be 4.7% [28]. These results are again about
Fig. 2 Incidence of blood loss more than 1000 mL at each maternity unit during 2017. Funnel plot of the number of bleeds more than 1000 mL
per 1000 maternities during 2017 at each obstetric unit in Wales
Table 2 Incidence of postpartum haemorrhage in Wales dependent on mode of delivery
Unassisted
vaginal
Instrumental
vaginal
Elective caesarean
section
Non-elective caesarean
section
Estimated maternities in Wales in 2017 20,055 3106 4193 3987
Number (95% CI) blood loss > 1000mL per 100
maternities
4.9
[4.6–5.2]
18.4
[17.1–19.8]
8.5
[7.7–9.4]
19.8
[18.6–21.0]
Number (95% CI) blood loss > 1500mL per 100
maternities
2.1
[1.9–2.3]
6.8
[6.0–7.78]
2.9
[2.4–3.4]
8.2
[7.4–9.1]
Number (95% CI) blood loss > 2000mL per 100
maternities
0.80
[0.68–0.93]
2.7
[2.2–3.3]
1.0
[0.74–1.4]
3.3
[2.8–3.9]
Bell et al. BMC Pregnancy and Childbirth          (2020) 20:271 Page 5 of 9
Ta
b
le
3
To
ta
lb
lo
od
lo
ss
fo
r
al
lm
at
er
ni
tie
s
an
d
in
ci
de
nc
e
of
bl
ee
ds
>
50
0
m
L
To
ta
lm
ea
su
re
d
bl
oo
d
lo
ss
(m
L)
M
ed
ia
n
(2
5t
h
to
75
th
pe
rc
en
t)
Po
st
pa
rt
um
ha
em
or
rh
ag
e
≥
50
0
m
L
In
ci
de
nc
e
(9
5%
C
I)/
10
0
m
at
er
ni
tie
s
U
ni
t
M
at
er
ni
tie
s
in
cl
ud
ed
in
an
al
ys
is
A
ll
m
at
er
ni
tie
s
U
na
ss
is
te
d
va
gi
na
l
de
liv
er
y
In
st
ru
m
en
ta
l
va
gi
na
l
de
liv
er
y
El
ec
tiv
e
ca
es
ar
ea
n
se
ct
io
n
C
at
eg
or
y
4
N
on
El
ec
tiv
e
ca
es
ar
ea
n
se
ct
io
n
C
at
eg
or
y
1–
3
A
ll
m
at
er
ni
tie
s
U
na
ss
is
te
d
va
gi
na
l
de
liv
er
y
In
st
ru
m
en
ta
l
va
gi
na
l
de
liv
er
y
El
ec
tiv
e
ca
es
ar
ea
n
se
ct
io
n
C
at
eg
or
y
4
N
on
El
ec
tiv
e
ca
es
ar
ea
n
se
ct
io
n
C
at
eg
or
y
1–
3
1
66
22
30
0
(2
00
–5
00
)
30
0
(2
00
–4
00
)
50
0
(3
00
–8
00
)
45
0
(3
00
–7
00
)
50
0
(3
50
–7
50
)
30
.9
[2
9.
8–
32
.0
]
18
.1
[1
6.
9–
19
.3
]
53
.8
[5
0.
6–
57
.0
]
48
.8
[4
5.
4–
52
.3
]
55
.4
[5
1.
8–
59
.0
]
2
24
1
42
1
(2
65
–6
51
)
30
1
(1
99
–4
50
)
53
2
(3
44
–9
61
)
80
0
(5
33
–1
16
5)
60
2
(4
38
–8
90
)
40
.7
[3
4.
7–
47
.0
]
17
.4
[1
2.
0–
24
.6
]
53
.8
[3
5.
5–
71
.2
]
88
.6
[7
4.
0–
95
.5
]
69
.0
[5
4.
0–
80
.9
]
3
92
5
40
0
(2
50
–7
32
)
28
3
(1
57
–4
48
)
60
0
(4
00
–1
00
0)
55
9
(3
61
–8
20
)
70
0
(4
37
–9
40
)
40
.4
[3
7.
3–
43
.6
]
18
.6
[1
5.
4–
22
.3
]
66
.7
[5
6.
1–
75
.8
]
55
.0
[4
7.
5–
62
.2
]
70
.7
[6
3.
9–
76
.7
]
4
89
2
40
0
(2
45
–7
00
)
30
0
(1
99
–4
50
)
50
0
(3
33
–8
60
)
54
3
(4
13
–8
50
)
67
7
(4
54
–9
11
)
39
.1
[3
6.
0–
42
.4
]
19
.1
[1
6.
0–
22
.7
]
55
.7
[4
5.
3–
65
.6
]
68
.3
[5
9.
6–
76
.0
]
71
.7
[6
4.
4–
78
.0
]
A
ll
86
80
35
0
(2
19
–6
00
)
30
0
(2
00
–4
00
)
50
0
(3
00
–8
50
)
50
0
(3
00
–7
50
)
55
0
(3
69
–8
50
)
33
.0
[3
2.
0–
34
.0
]
18
.2
[1
7.
2–
19
.3
]
54
.9
[5
2.
0–
57
.8
]
53
.0
[5
0.
1–
55
.9
]
60
.9
[5
8.
0–
63
.7
]
Bell et al. BMC Pregnancy and Childbirth          (2020) 20:271 Page 6 of 9
50% lower than the 8.6% reported here. A recent inter-
ventional clinical trial of women having a vaginal deliv-
ery that measured blood loss with under buttock drapes,
reported PPH > 1000mL to be 8.1% with intramuscular
oxytocin [29] and 4.6% with intravenous oxytocin, simi-
lar to our results in one arm of the study.
It is very likely that quantitative measurement of
blood loss from delivery with standardisation across
hospitals providing maternity care contributed to the
high incidence of PPH observed in this report. Shields
et al. reported a quality improvement programme in
California that introduced blood loss measurement as
part of a comprehensive approach to PPH and found
that bleeds > 1500 mL increased from 2.7 to 4.3% (a
159% increase) [9]. This is similar to the incidence re-
ported in Wales where we observed an increase of
165% from 2 to 3.3%. The observed increase in PPH
> 1500 mL is remarkably similar between the two
studies and indicates that quantitative measurement
detects more cases of severe PPH than visual estima-
tion. Whilst the possibility that there was an actual
165% increase in PPH over a 1 year period in Wales
cannot be excluded, this is unlikely because the
change is so large and the demographics of the popu-
lation and obstetric practice did not change and the
increase is almost identical to that observed by
Shields et al. During this time prophylactic utero-
tonics were recommended for active management of
the 3rd stage of labour for all deliveries in Wales
[30]. The different methods of data collection be-
tween 2016 and 2017 may have also contributed to
the observed increase. In OBS Cymru, maternity units
measure all bleeding, rather than start at the time of
clinical concern [1], and do this cumulatively in real
time. This is likely to increase identification of cases
where blood loss is between 500 and 1500 mL. Cumu-
lative measurement alerts clinicians to progression of
bleeding and prompts escalation of care to more se-
nior clinicians at an appropriate time, as described in
guidelines and previous studies [1, 8].
We observed a large difference in the incidence of PPH
between different modes of delivery with instrumental vagi-
nal deliveries and emergency caesarean sections being sub-
stantially higher than elective caesarean section and
unassisted vaginal delivery. This may, in part, be due to dif-
ference in the modes of volumetric and gravimetric meas-
urement. However, the correlation between fall in
haemoglobin for each mode of delivery was similar (manu-
script accepted), indicating that the method worked ad-
equately well in both situations. This suggests that the
difference in observed blood loss is unlikely to be due to the
method of measurement alone. Stafford et al. reported that
if visual estimation is used blood loss appears to be similar
between spontaneous and operative vaginal deliveries
(median 250 vs 300mL) but dissimilar if blood loss is calcu-
lated based on fall in haemoglobin (574mL vs 728mL) [31].
It is reported that blood loss measurement alone does
not reduce PPH rates [6, 14]. A cluster randomised
study comparing systematic use of a collector bag with
visual estimation found no difference between the two
arms [32]. A Cochrane review identified two studies that
met the pre-specified inclusion criteria and concluded
that there were insufficient data to support the use of ei-
ther estimated or quantitative blood loss, highlighting
the need for high quality trials in the field [21]. Cumula-
tive, quantitatively measured blood loss has potential
value when integrated into a multidisciplinary escalation
policy to inform team interventions with the aim of pre-
venting small or moderate bleeds becoming severe. Im-
proved outcomes have been shown in the context of this
integrated approach both in single centre reports and
large quality improvement programmes [9, 23].
The main strength of this report is that it is a large, pro-
spective, real world, consecutive cohort of all maternities
in Wales covering both midwifery- and obstetrician-led
births. It provides new and consistent data on blood loss
after different modes of birth. The report involves multiple
maternity units of different sizes, case mix and staffing
levels. The rates of vaginal and caesarean delivery across
Wales are representative of the UK suggesting that they
are applicable to other regions (https://files.digital.nhs.uk/
pdf/l/1/hosp-epis-stat-mat-repo-2016-17.pdf, accessed
14th Mar 2020). There was a high level of sustained com-
pliance with quantitatively measured blood loss and re-
markably consistent results.
Limitations of the analysis are that blood loss data
linked to mode of delivery for all maternities are available
from only 4 units, although this subgroup includes more
than 8000 maternities and the rate of PPH ≥500mL was
almost identical to the whole of Wales. Quantitative meas-
urement was performed at all sites although we cannot be
certain of the accuracy of measurement. It is likely, how-
ever, that the findings are more accurate than for visually
estimation. Accurate quantification of amniotic fluid re-
mains a challenge for both quantitative and estimated
techniques. In addition, QBL measurement was not inte-
grated into community based midwifery led births until
2019. During 2017, all women giving birth in community-
based midwifery-led birth facilities who experienced PPH
> 1000ml were transferred to the closest hospital and in-
cluded in the receiving institutions data collection.
In conclusion, quantitative measurement of peri-partum
blood loss has become standard practice in Wales and has
been associated with improved detection of PPH. Stand-
ardisation of blood loss measurement is important for un-
derstanding trends in the incidence of PPH and how bleed
volume affects PPH-related morbidity. Defining the
amount of blood loss to be expected at the time of delivery
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is important for assessing the impact of interventions aim-
ing to reduce PPH and to compare research studies. Al-
though uncontrolled reports in the context of quality
improvement suggest that cumulative, quantitative meas-
urement of blood loss, integrated into co-ordinated multi-
disciplinary care of PPH, improves outcomes such as need
for transfusion [9] these findings need to be investigated
in high quality trials to assess whether clinically relevant
outcomes are genuinely improved.
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